Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor"
The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as ...
treatment guidance, and monitoring of cancer. The company has various products under Screening Tests (Cologuard Test, Clinical Genetic Testing), Precision Oncology Tests (Oncotype DX Breast Recurrence Score Test, OncoExTra Test), and COVID-19 Testing...
GSK has also made a major push into oncology R&D, but that effort hasn’t yielded high returns. PARP inhibitor Zejula didwinan important FDA clearance as a first-line maintenance therapy for ovarian cancer patients who respond to an initial round of chemo, regardless of BRCA mutation status. ...
US oncology biopharma, expansion of UK footprint Proclinical Group 19 Sep 24 Impact of AI drug discovery today and in the future Hannah Burke 19 Sep 24 Who are the top 10 oncology companies in the world? (2024) Hannah Burke 10 Sep 24 Growing international US biotech, European medi...
Takeda is focused on long-term profitable growth through six business drivers. These include our four core therapy areas of Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI), and additionally Plasma-Derived Therapies (PDT) and Vaccines. ...
Although, majority of the company’s CAR T pipeline is focused on oncology, the company is also evaluating a CAR T cell therapy candidate for treatment of autoimmune disorder, systemic lupus erythematosus. Novartis is engaged in the development of following CAR T cell therapies: Drug Candidate ...
Amgen has formed several strong partnerships including with AstraZeneca, to work on a drug for colorectal cancer; it has also been investing in artificial intelligence through its partnership with Owkin, particularly in the areas of cardiology, hematology and oncology. It is also regularly ranke...
contributing to 30% of annual revenue. New Oncology medicines were introduced, as well, adding to the revenue. During the 2020 pandemic, AstraZeneca was one of the first companies to initiate vaccine research and was one of the first companies to take out the vaccine in several countries, und...
The acquisition of ImmunoGen, valued at $10.1 billion, and the definitive transaction worth $8.7 billion to acquire Cerevel Therapeutics, will enhance AbbVie's oncology and neuroscience portfolios. GSK has witnessed a 17.7% market capitalization growth, fueled by a 12% rev...